Unfolding the Mystery of IHC vs IF The tale of modern medicine would be incomplete without the mention of the revolutionary tools that researchers employ in their quest to unravel the complex mechanisms of life and disease. Among these, two techniques stand out – Immunofluorescence (IF) and Immunohistochemistry (IHC). These methodologies, each with its unique…
Find out more
In the complex journey of drug development, toxicology studies play an indispensable role. They provide vital insights into the safety profile of novel drug candidates and form a key component of regulatory submissions to bodies like the U.S. Food and Drug Administration (FDA). This blog post intends to explore the realm of toxicology studies in…
Find out more
In the fascinating world of pharmaceutical breakthroughs, the immense value of GLP-guided toxicological analyses (GLP Tox) cannot be overstated. Toxicology, which examines the harmful effects of chemicals on living organisms, plays an essential role in the complex realm of drug discovery. GLP toxicity studies, conducted within this framework, serve as a pivotal tool for predicting…
Find out more
Ever wonder how we peer into the microscopic world of cells and tissues? Welcome to the fascinating realm of histology! It’s a science that’s pivotal to everything and plays a critical role in numerous scientific and medical endeavours from cutting-edge research to clinical diagnoses and drug development. But what does the journey of a tiny…
Find out more
We're thrilled to announce that we've recently added Visiopharm to our Digital Pathology service, alongside the gold standard image analysis platform, HALO™ from Indica Labs.
Find out more
To mark British Science Week and Women’s History Month we spoke to Rebecca Hanwell about her experiences studying science. Q: Can you tell us about your research progress since completing your MPhil research project at HistologiX? A: Since completion of the MPhil, I have tested Human papillomavirus (HPV) antibodies using immunohistochemical methods on tissue. My…
Find out more
We’re thrilled to announce that HistologiX will be attending the upcoming Scottish Life Sciences Awards, alongside our sister company from the Niche CRO Group, Intelligent Clinical. The Scottish Life Sciences Awards is a prestigious event that recognises the achievements and contributions of companies and individuals in the life sciences sector. It’s an honour to be…
Find out more
HistologiX is proud to announce that we will be attending the Medilink Midlands Business Awards 2023, where we have been nominated for the Partnership between Academia and Business award. The Medilink Midlands Business Awards recognises and celebrates the achievements of businesses and individuals in the healthcare and life sciences sector. The Partnership between Academia and…
Find out more
If you’ve conducted a Tissue Cross-Reactivity (TCR) study and are planning to bring a biologic to market, chances are you’ll need approval from a regulatory body. In the United States that regulatory body is the Food and Drug Administration (FDA) and the FDA has been regulating TCR studies since 1983. History of the FDA Tissue…
Find out more
As experts in cellular and digital pathology, we often get asked about the importance of Tissue cross-reactivity (TCR) studies especially by people new to the drug development process. These studies are an essential tool for evaluating the binding properties of biologics, in different human and non-human tissues. They form a crucial part of the regulatory…
Find out more